Study of telomerase activity, proliferation and differentiation characteristics in umbilical cord blood mesenchymal stem cells
Authors
Abstract:
In recent years, considerable advances have been made in the field of regenerative medicine. Unlikeembryonic stem cells, which pose the problems of ethical concerns and cause severe immunological reactions as well as neoplasma formation after transplantation, umbilical cord blood is a primitive source ofmesenchymal stem cells that covers the benefits of both embryonic and adult stem cells. It has beendetermined that the proliferation capacity of cells is critically linked to the maintenance of the length oftelomeres by telomerase activity. Since there is no information accessible regarding the pattern of telomerase activity in UCB-MSCs through several passages, the aim of this study was the evaluation of telomerase activity in UCB-MSCs, as a predisposing factor for cell immortalization. No telomerase activity was detectedin UCB-MSCs from several passages applying telomerase rapid amplification protocol (TRAP). Since thereis a direct correlation between the activation of telomerase expression and neoplasma formation in adultsomatic cells, UCB can be assumed as an excellent source of MSCs for therapeutic application with a highlevel of safety. According to the histological results, RT-PCR and biochemical assays, MSCs derived fromUCB showed high differentiation capacity to bone and cartilage. UCB-MSCs showed very low level ofdifferentiation potential to adipocytes. Our results showed that UCB-MSCs maintain their self-renewal anddifferentiation potential through several passages. Since a large number of metabolically active cells must be available in cell therapy, high proliferation capacity through several passages is a great advantage for large scale expansion of UCB-MSCs.
similar resources
study of telomerase activity, proliferation and differentiation characteristics in umbilical cord blood mesenchymal stem cells
in recent years, considerable advances have been made in the field of regenerative medicine. unlikeembryonic stem cells, which pose the problems of ethical concerns and cause severe immunological reactions as well as neoplasma formation after transplantation, umbilical cord blood is a primitive source ofmesenchymal stem cells that covers the benefits of both embryonic and adult stem cells. it h...
full textIn-vitro Differentiation of Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells to Insulin-Producing Cells
Background & Objective: Diabetes is a major chronic metabolic disease in the world. Islet transplantation is a way to treat diabetes. Unfortunately, this method is restricted due to graft rejection and lack of donor islets. Mesenchymal Stem Cells (MSCS) have the ability to differentiate into Insulin-Producing Cells (IPCs). In this study, Human Umbilical Mesenchymal Stem Cells (HUMSCS) were in...
full textDifferentiation of Umbilical Cord Lining Membrane-Derived Mesenchymal Stem Cells into Endothelial-Like Cells
Background: Stem cell therapy for the treatment of vascular-related diseases through functional revascularization is one of the most important research areas in tissue engineering. The aim of this study was to investigate the in vitro differentiation of umbilical CL-MSC into endothelial lineage cells. Methods: In this study, isolated cells were characterized for expression of MSC-specific marke...
full textHypoxia Preconditioning Promotes Survival And Clonogenic Capacity Of Human Umbilical Cord Blood Mesenchymal Stem Cells
Background: In recent decade, human umbilical cord blood derived mesenchymal stem cells (hUCB-MSCs) provide enormous potential for appropriate cell therapy, but they have limited growth potential and cease to proliferate due to cellular senescence, so providing a strategy for increasing the stem cell survival is necessary. Methods: In this investigation, MSCs characterized by flow cytome...
full textImproving the neuronal differentiation efficiency of umbilical cord blood-derived mesenchymal stem cells cultivated under appropriate conditions
Objective(s): Umbilical cord blood-derived mesenchymal stromal cells (UCB-MSCs) are ideally suited for use in various cell-based therapies. We investigated a novel induction protocol (NIP) to improve the neuronal differentiation of human UCB-MSCs under appropriate conditions. Materials and Methods: This experimental study was performed in Iranian Blood Transfusion Organization (IBTO), Tehran, I...
full textA New Two Step Induction Protocol for Neural Differentiation of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells
Background: In this study, we examined a new two step induction protocol for improving the differentiation of human umbilical cord blood-derived mesenchymal stem cells into neural progenitor cells. Materials and Methods: Human umbilical cord blood-derived mesenchymal stem cells were first cultured in Dulbecco’s modified eagle medium supplemented with 10% fetal bovine serum in a humidified incu...
full textMy Resources
Journal title
volume 13 issue 3
pages 176- 185
publication date 2012-09-20
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023